Delivery Order SPE2DB22D2005-SPE2DB26FJES4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,098.09 to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (3-count). This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, issued under a non-set-aside competitive procurement. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,015.60 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package). The contract, issued on April 21, 2025, with an ultimate completion date of April 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,610.48 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-unit supply) on June 20, 2025, with an ultimate completion date of June 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,948.40 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package), effective August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs under this delivery order at its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $5,477.59 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 3, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $1,179.78 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract, this delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,339.62 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units). This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, was competitively awarded with no set-aside designation. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,038.24 on August 19, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (3-pack units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, due for completion by August 20, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child transaction...
- The Defense Logistics Agency awarded a delivery order valued at $3,988.76 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count). This firm fixed-price, competitively awarded contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,945.86 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day patches (3-count units), with an ultimate completion date of July 21, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its Corporate Office location. This award represents a single transaction under the company's...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB26FJES4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package). This firm fixed price, non-competitive delivery order was issued on October 28, 2025, with an ultimate completion date of October 29, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds an extensive portfolio of federal contracts with DLA covering a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. The underlying IDC provides a flexible vehicle enabling AmerisourceBergen to supply medications, vaccines, and medical devices to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. This specific delivery order for Xulane patches represents one of numerous small-value transactions executed under the prime contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 10/28/25 |